IAN SMALLING: Open Payments
NPI 1114971033 · SUGAR LAND, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,035 in 46 payments from 13 companies in 2025. Trend: 2023 $1,469 · 2024 $1,076 · 2025 $1,035
Food & beverage: $1,035
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 8 | $179 |
| E.R. Squibb & Sons, L.L.C. | 6 | $157 |
| ABBVIE INC. | 7 | $139 |
| Vanda Pharmaceuticals Inc. | 5 | $100 |
| Corium, LLC | 4 | $91 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $86 |
| Lundbeck LLC | 3 | $69 |
| Otsuka America Pharmaceutical, Inc. | 3 | $64 |
| Neurocrine BioSciences, Inc. | 2 | $59 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $43 |
Products named: Auvelity, COBENFY, VRAYLAR, REXULTI, FANAPT, Azstarys, TRINTELLIX, INGREZZA.
Industry payments across TX — which companies pay providers there.
